Navidea Biopharmaceuticals Inc. announced that it has executed a Letter of Intent (LOI) with Cardinal Health for the sale of all rights, title and interest to Navidea’s Lymphoseek product. The agreement covers all U.S. Food and Drug Administration (FDA)-approved, pending and future oncology diagnostic indications in North America, subject to certain limitations, as well as certain other related assets. Under the terms of the LOI, Navidea would receive $80 million at closing, with future consideration tied to annual sales of the Lymphoseek product and certain sales-based milestones. Total consideration to Navidea would be capped at $310 million.

September 6, 2016 — IBA (Ion Beam Applications S.A.) and RaySearch Laboratories have entered into a long-term strategic alliance to combine their respective technologies and advance adaptive proton therapy.

autism severity, diagnostic ultrasound, link, UW stud, genetics

September 2, 2016 — For children with autism and a class of genetic disorders, diagnostic ultrasound exposure in the first trimester of pregnancy is linked to increased autism severity, according to a new study. The study was conducted by researchers at University of Washington (UW) Medicine, UW Bothell and Seattle Children's Research Institute.

September 2, 2016 — Clear Image Devices LLC announced it will be displaying a new product, the Bucky Protector, at the 2016 Radiological Society of North America (RSNA) annual meeting, Nov. 27-Dec. 2 in Chicago.

Mayfair Diagnostics, a medical imaging clinic in Calgary, Alberta, is revealing its newest medical imaging clinic in Coventry Hills, which is being described as the clinic of the future because of the way it was designed.

September 2, 2016 — The University of Mississippi Medical Center (UMMC) recently signed an agreement to build its imaging management strategy on Agfa Healthcare’s Enterprise Imaging platform.

Carestream announced it has begun shipping its new DRX Core family of DRX detectors. The new detectors are designed to make reliable, high-quality digital radiography (DR) imaging affordable for imaging centers, small to mid-size hospitals, urgent care facilities, specialty clinics and providers that perform mobile imaging exams.

September 1, 2016 — The American Society for Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) e-published a new position statement supporting myocardial perfusion positron emission tomography (PET) in the diagnosis and management of coronary artery disease.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now